UPC
Universe Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CN
$1.47
−1.34%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.13x
- Price / sales
- 0.42x
- Price / cash flow
- -0.62x
Enterprise value
- Enterprise value
- -$12.1M
- EV / sales
- -0.68x
- EV / EBITDA
- 9.28x
- EV / EBIT
- 5.80x
- Market cap
- $7.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026